NCT05806528

Brief Summary

This study will be conducted on women who have a diagnosis of placenta previ and using ultrasound to make the placenta invasion index and compare the accuracy of the diagnosis during the caesarean section whether it is accreta or not with determining the site and depth of invasion

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2023

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 28, 2023

Completed
4 days until next milestone

Study Start

First participant enrolled

April 1, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

April 10, 2023

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2024

Completed
Last Updated

April 10, 2023

Status Verified

March 1, 2023

Enrollment Period

9 months

First QC Date

March 28, 2023

Last Update Submit

March 28, 2023

Conditions

Placenta Accreta

Outcome Measures

Primary Outcomes (1)

  • Role of placental invasion index in decision making of placenta accreta

    Use of ultrasound to make placenta invasion index and compare it intraoperative

    1 year

Interventions

UltrasoundOTHER

Use ultrasound to make placental invasion index

Eligibility Criteria

Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsPregnant female
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Pregnant female with placenta previa

You may qualify if:

  • all placenta previa and low laying placenta will be included

You may not qualify if:

  • patient with sever attack

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Placenta Accreta

Interventions

High-Energy Shock Waves

Condition Hierarchy (Ancestors)

Obstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesPlacenta Diseases

Intervention Hierarchy (Ancestors)

Ultrasonic WavesSoundRadiation, NonionizingRadiationPhysical Phenomena

Study Officials

  • Mariam S Mahmoud, Resident

    Sohag univesity hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Mariam s Mahmoud, Resident

CONTACT

01061816280mariamsabri20@gmail.com

Mariam SM Mahmoud, Resident

CONTACT

01061816280mariamsabri20@gmail.com

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident at GYN/OBS department

Study Record Dates

First Submitted

March 28, 2023

First Posted

April 10, 2023

Study Start

April 1, 2023

Primary Completion

January 1, 2024

Study Completion

March 1, 2024

Last Updated

April 10, 2023

Record last verified: 2023-03